Evidence map›Paper›PMID 30577606›Full record

ArticleMicroorganisms2018

Susceptibility of Virulent

Riccardo Russo, Irina Kolesnikova, Thomas Kim, Shilpi Gupta, Androulla Pericleous, Daniel E Kadouri, Nancy D Connell

Abstract read
In one paragraph

Article in Microorganisms, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. The antibiotic crisis: How bacterial predators can help.Computational and structural biotechnology journal · 2020
    Review
  12. Biotechnological Potential ofFrontiers in microbiology · 2020
    Review
  13. Pathogens (Basel, Switzerland) · 2019
    Article
  14. Inner Workings: Probing predatory bacteria as an antibacterial remedy.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  15. Community- and Hospital-AcquiredMicroorganisms · 2019
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Riccardo RussoDepartment of Medicine and the Center for Emerging Pathogens, Rutgers, New Jersey Medical School, Newark, NJ 07101, USA. russori@njms.rutgers.edu.
Irina KolesnikovaDepartment of Medicine and the Center for Emerging Pathogens, Rutgers, New Jersey Medical School, Newark, NJ 07101, USA. kolesnir@njms.rutgers.edu.
Thomas KimDepartment of Medicine and the Center for Emerging Pathogens, Rutgers, New Jersey Medical School, Newark, NJ 07101, USA. tk473@njms.rutgers.edu.
Shilpi GuptaDepartment of Oral Biology, Rutgers School of Dental Medicine, Newark, NJ 07101, USA. sg1135@sdm.rutgers.edu.
Androulla PericleousDepartment of Oral Biology, Rutgers School of Dental Medicine, Newark, NJ 07101, USA. andrea83@gsbs.rutgers.edu.
Daniel E KadouriDepartment of Oral Biology, Rutgers School of Dental Medicine, Newark, NJ 07101, USA. kadourde@sdm.rutgers.edu.
Nancy D ConnellDepartment of Medicine and the Center for Emerging Pathogens, Rutgers, New Jersey Medical School, Newark, NJ 07101, USA. NancyConnell@jhu.edu.

Funding

Defense Advanced Research Projects Agency Cooperative Agreement Number W911NF-15-2-0036
6 · The paper itself

Abstract

Multi-drug resistant bacterial infections are a serious threat to global public health. Changes in treatment modalities and prudent use of antibiotics can assist in reducing the threat, but new approaches are also required for untreatable cases. The use of predatory bacteria, such as

Indexed as

Bdellovibriolung infectionpredatory bacteriaselect agent countermeasureYersinia pestis

Identifiers

PMID30577606
PMCPMC6351954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.